A legacy that inspires the Future.
From the first guidewire to the first drug-eluting stent, Cordis has been at the heart of cardiovascular innovation for nearly 70 years. Today, Cordis drives transformation through internal development, Cordis-X partnerships, and strategic acquisitions—powered by a global footprint and deep operational expertise. With a focus on better clinical outcomes, customer-centered service, and impactful education, Cordis will Go Beyond to relentlessly pursue its mission to transform cardiovascular care.
SELUTION SLRTM PTCA Drug-Eluting Balloon (DEB)
Continuing to pioneer sirolimus technologies, Cordis is introducing SELUTION SLR PTCA DEB – the first and only sirolimus DEB available in the US and the first and only DEB validated against Standard of Care for ISR.
Advancing the Future of Coronary Drug-Eluting Balloons
Introducing the first sirolimus drug-eluting balloon available in the United States for coronary ISR. Combining sustained sirolimus delivery with contemporary clinical evidence, SELUTION SLR DEB expands treatment options without adding another permanent metal layer.
MYNX CONTROL VENOUS Vascular Closure Device
MYNX CONTROL VENOUS VCD is designed to pair procedural simplicity with enhanced safety & reliability, achieving rapid hemostasis*.
* Cordis 2024 Data on File.
MYNX CONTROL VENOUS Vascular Closure Device
SABER PTA Catheter Portfolio
The comprehensive SABER® PTA Dilatation Catheter Portfolio is engineered to provide exceptional crossability, deliverability, and a wide variety of sizes and shaft lengths, enabling physicians to treat a broad range of lesions from multiple access sites.
Radial Portfolio
From the proprietary KINK RECOVERY TECHNOLOGY™ of the RAIN Sheath® Transradial Thin-walled Introducer to the ZEPHYR® Vascular Compression Band that offers comfort, flexibility and patent hemostasis for radial closure, the Radial Portfolio offers the products you can depend on from access to closure.
Driven by mission, guided by values
Cordis is making a difference. We impact millions of lives, in more than 60 countries around the world. We embrace a diverse, empowered culture where teammates are inspired to serve customers, patients and shareholders while fulfilling their own career aspirations.
News
Need Help?
We’re here with the support and information to help you make the right choices for your patients.